TABLE I.
Model Parameter | Symbol | Baseline Value | Reference |
---|---|---|---|
Hypoxia threshold | 1/3 normoxia | [44, 47] | |
Oxygen diffusion constant | D oxygen | 2.5 ×10−6cms−1 | [48] |
Blood oxygen concentration | 100 mmHg | [44] | |
Estrogen diffusion constant | D estrogen | 2.45 × 10−6 cm2 s−1 | * |
AREG diffusion constant | D AREG | 3.18 × 10−7 cm2 s−1 | [49]** |
Proliferation rate (frequency) | ≤ 1 per 16 hours | [50, 51] | |
Cell cycle time | 16 hours | [50, 51] | |
Progenitor symmetric proliferation probability | 100% | ||
Proliferation cycles before differentiation | P max | 50 | [52, 53] |
Stem cell symmetric proliferation probability | 12% | [54] | |
Mature mammary cell radius | r | 5μm | [51,55] |
Healthy cell oxygen consumption rate | 45 attoMol cell−1 sec−1 | [55] | |
Cancer cell oxygen consumption rate | 4.5x healthy cell rate | [55] | |
Hypoxia time to necrosis | 12 hours | [56] | |
Lysis volume increase due to swelling | 100% | [57, 58] | |
Lysis time | 6 hours | [59] | |
Time to calcification | 14 days | [60] | |
Calcified volume % of pre-lysis cell volume | 30% | [61] | |
Estrogen baseline† (% perturbation) | 0.85 (0.05) | ||
FGF baseline† (% perturbation) | 0.5 (0.1) |
Important model parameter baseline values. When not readily available in the literature, diffusion constants were estimated either through interpolation from values from structurally similar molecules (*) or from known values based on relative molecular weights (**). Other uncited values were determined from model calibration.
Normalized values. We have reduced the value for stem cell symmetric proliferation by 1% from [54].